12882 studies found for:    Canada
Show Display Options
Rank Status Study
1 Unknown  Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With Hodgkin's Lymphoma
Condition: Lymphoma
Interventions: Biological: bleomycin sulfate;   Drug: ABVD regimen;   Drug: Stanford V regimen;   Drug: cyclophosphamide;   Drug: dacarbazine;   Drug: doxorubicin hydrochloride;   Drug: etoposide;   Drug: mechlorethamine hydrochloride;   Drug: prednisone;   Drug: vinblastine;   Drug: vincristine sulfate;   Radiation: radiation therapy
2 Completed Study In People With Type 2 Diabetes
Conditions: Diabetes Mellitus, Type 2;   Non-Insulin-Dependent Diabetes Mellitus
Interventions: Drug: Pioglitazone;   Drug: GW677954
3 Completed Irinotecan With or Without Oxaliplatin in Treating Patients With Metastatic Colorectal Cancer
Condition: Colorectal Cancer
Interventions: Drug: irinotecan hydrochloride;   Drug: oxaliplatin
4 Terminated Niacin Plus Statin to Prevent Vascular Events
Conditions: Cardiovascular Diseases;   Heart Diseases;   Cerebrovascular Accident;   Coronary Disease;   Atherosclerosis;   Myocardial Infarction
Interventions: Drug: Extended release niacin;   Drug: Simvastatin
5 Terminated
Has Results
Safety and Tolerability of Memantine in Moderate to Severe Alzheimer's Disease
Condition: Alzheimer's Disease
Intervention: Drug: Memantine
6 Completed Canadian Active & Maintenance Modified Pentasa Study
Conditions: Active Ulcerative Colitis;   Remission of Ulcerative Colitis
Intervention: Drug: 5-ASA (5-Aminosalicylate)
7 Recruiting Further Cardiovascular Outcomes Research With PCSK9 Inhibition in Subjects With Elevated Risk
Condition: Dyslipidemia
Interventions: Biological: Evolocumab (AMG 145);   Other: Placebo;   Drug: Effective statin therapy
8 Completed Genetic Study in Patients With Stage II or Stage III Colon Cancer
Condition: Colorectal Cancer
Interventions: Genetic: DNA stability analysis;   Genetic: gene mapping
9 Completed Open Label Extension Study of PREOS
Condition: Osteoporosis
Intervention: Drug: ALX1-11 (drug)
10 Recruiting Cardiovascular Inflammation Reduction Trial
Condition: Cardiovascular Disease
Interventions: Drug: Methotrexate;   Drug: Placebo
11 Active, not recruiting PF-00299804 in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer That Has Not Responded to Standard Therapy for Advanced or Metastatic Cancer
Condition: Lung Cancer
Interventions: Drug: PF-00299804;   Drug: Placebo
12 Completed Radiation Therapy in Treating Patients With Metastases to the Lymph Nodes in the Neck From an Unknown Primary Tumor
Condition: Carcinoma of Unknown Primary
Intervention: Radiation: radiation therapy
13 Terminated
Has Results
Vaspect Study - An Open-Label Trial Of Donepezil in Vascular and Mixed Dementia
Conditions: Dementia, Vascular;   Dementia, Mixed
Intervention: Drug: Donepezil
14 Terminated Study of TAK-875 in Adults With Type 2 Diabetes and Cardiovascular Disease or Risk Factors for Cardiovascular Disease
Conditions: Type 2 Diabetes;   Cardiovascular Disease
Interventions: Drug: TAK-875;   Drug: TAK-875 Placebo
15 Terminated A Study of the Effect of Dalcetrapib on Artherosclerotic Disease in Patients With Coronary Artery Disease
Condition: Cardiovascular Disease
Interventions: Drug: Placebo;   Drug: dalcetrapib
16 Completed Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 2 Diabetes Mellitus on Basal Plus Mealtime Insulin
Condition: Type 2 Diabetes Mellitus
Interventions: Drug: HOE901-U300 (new formulation of insulin glargine);   Drug: Lantus (insulin glargine)
17 Completed
Has Results
A Phase III Trial of ZD4054 (Zibotentan) (Endothelin A Antagonist) in Hormone Resistant Prostate Cancer With Bone Metastases
Condition: Prostate Cancer
Interventions: Drug: ZD4054;   Drug: Placebo
18 Recruiting A Trial Comparing Combination Treatment (Solifenacin Plus Mirabegron) With One Treatment Alone (Solifenacin)
Conditions: Urinary Bladder Overactive;   Urinary Bladder Diseases;   Urologic Diseases
Interventions: Drug: Mirabegron;   Drug: Solifenacin succinate low dose;   Drug: Solifenacin succinate high dose
19 Completed PREventative Study Against URate-lowering Drug-induced Gout Exacerbations 1
Condition: Intercritical Gout
Intervention: Drug: rilonacept
20 Completed Combination Chemotherapy in Treating Patients With Advanced Colorectal Cancer
Condition: Colorectal Cancer
Interventions: Drug: FOLFOX regimen;   Drug: fluorouracil;   Drug: leucovorin calcium;   Drug: oxaliplatin

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years